Dr. Rothenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Drive, Alway Building M211
Mc5187
Stanford, CA 94305Phone+1 650-725-3362Fax+1 650-723-5488
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 2007 - 2010
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2005 - 2007
- University of California San Francisco School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis.Silvio Danese, Michael E Rothenberg, Jeremy J Lim, Han Ting Ding, Jacqueline M McBride
Clinical Gastroenterology and Hepatology. 2024-12-16 - Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc).Yanke Yu, Michael E Rothenberg, Han Ting Ding, Ari Brekkan, Gizette Sperinde
Journal of Pharmacokinetics and Pharmacodynamics. 2024-04-01 - Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects.Mariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico, Tatiana Goncharov, Joshua D Webster
Science Translational Medicine. 2023-12-20
Press Mentions
- Back-to-School Advice for Dealing with COVID-19, Stress and Learning LossAugust 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: